Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar;49(3):2325-2333.
doi: 10.1007/s11033-021-06963-0. Epub 2022 Jan 6.

RNA sequencing and its applications in cancer and rare diseases

Affiliations
Review

RNA sequencing and its applications in cancer and rare diseases

Selvi Ergin et al. Mol Biol Rep. 2022 Mar.

Abstract

With the invention of RNA sequencing over a decade ago, diagnosis and identification of the gene-related diseases entered a new phase that enabled more accurate analysis of the diseases that are difficult to approach and analyze. RNA sequencing has availed in-depth study of transcriptomes in different species and provided better understanding of rare diseases and taxonomical classifications of various eukaryotic organisms. Development of single-cell, short-read, long-read and direct RNA sequencing using both blood and biopsy specimens of the organism together with recent advancement in computational analysis programs has made the medical professional's ability in identifying the origin and cause of genetic disorders indispensable. Altogether, such advantages have evolved the treatment design since RNA sequencing can detect the resistant genes against the existing therapies and help medical professions to take a further step in improving methods of treatments towards higher effectiveness and less side effects. Therefore, it is of essence to all researchers and scientists to have deeper insight in all available methods of RNA sequencing while taking a step-in therapy design.

Keywords: Eukaryotic organisms; Gene-related diseases; Long-read; RNA sequencing; Short-read; Transcriptomes.

PubMed Disclaimer

Conflict of interest statement

The author declares that they have no conflict of interest.

References

    1. Crick F. Central dogma of molecular biology. Nature. 1970;227:561–563. - PubMed
    1. Crick FH. On protein synthesis. Symp Soc Exp Biol. 1958;12:138–163. - PubMed
    1. Wang B, Kumar V, Olson A, Ware D. Reviving the transcriptome studies: an insight into the emergence of single-molecule transcriptome sequencing. Front Genet. 2019;10:384. doi: 10.3389/fgene.2019.00384. - DOI - PMC - PubMed
    1. Saliba AE, Westermann AJ, Gorski SA, Vogel J. Single-cell RNA-seq: advances and future challenges. Nucleic Acids Res. 2014;42:8845–8860. doi: 10.1093/nar/gku555. - DOI - PMC - PubMed
    1. Hangauer MJ, Vaughn IW, McManus MT. Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs. PLoS Genet. 2013;9:e1003569. doi: 10.1371/journal.pgen.1003569. - DOI - PMC - PubMed